The management of Staphylococcus aureus bacteremia in the United Kingdom and Vietnam: A multi-centre evaluation

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Thwaites, Guy E ^a   Duong, Trinh ^b   de Silva, Chanaka ^c   Edgeworth, Jonathan ^d   Hopkins, Susan ^e   Klein, John ^d   Kirby, Andrew ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; FLUCLOXACILLIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; MACROLIDE; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CATHETER INFECTION; CLINICAL FEATURE; CONTROLLED STUDY; DRUG CHOICE; ECHOCARDIOGRAPHY; FEMALE; HOSPITAL CARE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NEPAL; PRACTICE GUIDELINE; PROSPECTIVE STUDY; SOFT TISSUE INFECTION; STAPHYLOCOCCAL BACTEREMIA; TREATMENT DURATION; UNITED KINGDOM; VIET NAM; AGE; BACTEREMIA; CLINICAL TRIAL; METABOLISM; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

STAPHYLOCOCCUS AUREUS;

ADULT; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; ECHOCARDIOGRAPHY; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NEPAL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIETNAM;

EID: 78650792286     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014170     Document Type: Article

References (27)

1. Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, et al. (2006) Healthcareassociated bloodstream infection: A distinct entity? Insights from a large U.S. database. Crit Care Med 34: 2588-2595.
2. Health Protection Agency. Communicable Disease Surveillance Centre DoH (2009) Summary points and commentary on Quarterly (April 2006 to December 2008) and financial year (April 2006 to March 2008) MRSA bacteraemia data derived from Mandatory Surveillance, March 2009.
3. Wyllie DH, Crook DW, Peto TE (2006) Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 333: 281.
4. Nickerson EK, Hongsuwan M, Limmathurotsakul D, Wuthiekanun V, Shah KR, et al. (2009) Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance. PLoS One 4: e4308.
5. Nickerson EK, Wuthiekanun V, Wongsuvan G, Limmathurosakul D, Srisamang P, et al. (2009) Factors predicting and reducing mortality in patients with invasive Staphylococcus aureus disease in a developing country. PLoS One 4: e6512.
6. Hoa NT, Diep TS, Wain J, Parry CM, Hien TT, et al. (1998) Communityacquired septicaemia in southern Viet Nam: the importance of multidrugresistant Salmonella typhi. Trans R Soc Trop Med Hyg 92: 503-508.
7. Tran TS, Jamulitrat S, Chongsuvivatvong V, Geater A (1998) Postoperative hospital-acquired infection in Hungvuong Obstetric and Gynaecological Hospital, Vietnam. J Hosp Infect 40: 141-147.
8. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr., Bolger AF, et al. (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111: e394-434.
9. Elliott TS, Foweraker J, Gould FK, Perry JD, Sandoe JA (2004) Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 54: 971-981.
10. Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, et al. (2006) Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 57: 589-608.
11. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, et al. (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheterrelated infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49: 1-45.
12. Dryden M, Andrasevic AT, Bassetti M, Bouza E, Chastre J, et al. (2010) A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice. Clin Microbiol Infect 16 Suppl 1: 3-30.
13. Naber CK, Baddour LM, Giamarellos-Bourboulis EJ, Gould IM, Herrmann M, et al. (2009) Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus. Clin Infect Dis 48 Suppl 4: S260-270.
14. Hussain A, Alleyne S, Jenkins D (2010) A survey of attitudes towards methicillinresistant Staphylococcus aureus bacteraemias amongst United Kingdom microbiologists. J Antimicrob Chemother 65: 347-349.
15. Ammerlaan H, Seifert H, Harbarth S, Brun-Buisson C, Torres A, et al. (2009) Adequacy of Antimicrobial Treatment and Outcome of Staphylococcus aureus Bacteremia in 9 Western European Countries. Clin Infect Dis.
16. Wong V, Wariyar R, Weston V, Olver WJ, Youngs E, et al. (2010) Audit of treatment of Staphylococcus aureus bacteraemia. Clinical Medicine 10: 266-269.
17. Tai BC, Peregoudov A, Machin D (2001) A competing risk approach to the analysis of trials of alternative intra-uterine devices (IUDs) for fertility regulation. Stat Med 20: 3589-3600.
18. Fine J, Gray R (1999) A proportional hazards model for the subdistribution of competing risk. J Am Stat Assoc 94: 496-509.
19. Royston P (2004) Multiple imputation of missing data. Stata Journal 4: 227-241.
20. Nickerson EK, West TE, Day NP, Peacock SJ (2009) Staphylococcus aureus disease and drug resistance in resource-limited countries in south and east Asia. Lancet Infect Dis 9: 130-135.
21. Fowler VG, Jr., Li J, Corey GR, Boley J, Marr KA, et al. (1997) Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 30: 1072-1078.
22. Sullenberger AL, Avedissian LS, Kent SM (2005) Importance of transesophageal echocardiography in the evaluation of Staphylococcus aureus bacteremia. J Heart Valve Dis 14: 23-28.
23. Fowler VG, Jr., Sanders LL, Sexton DJ, Kong L, Marr KA, et al. (1998) Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 27: 478-486.
24. Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhoj P, et al. (2002) Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 162: 25-32.
25. Turnidge JD, Kotsanas D, Munckhof W, Roberts S, Bennett CM, et al. (2009) Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust 191: 368-373.
26. Lesens O, Hansmann Y, Storck D, Christmann D (2003) Risk factors for metastatic infection in patients with Staphylococcus aureus bacteremia with and without endocarditis. Eur J Intern Med 14: 227-231.
27. Melzer M, Eykyn SJ, Gransden WR, Chinn S (2003) Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 37: 1453-1460.